104 related articles for article (PubMed ID: 25868656)
1. A conjugate of the lytic peptide Hecate and gallic acid: structure, activity against cervical cancer, and toxicity.
Sanches PR; Carneiro BM; Batista MN; Braga AC; Lorenzón EN; Rahal P; Cilli EM
Amino Acids; 2015 Jul; 47(7):1433-43. PubMed ID: 25868656
[TBL] [Abstract][Full Text] [Related]
2. Targeted destruction of normal and cancer cells through lutropin/choriogonadotropin receptors using Hecate-betaCG conjugate.
Zaleska M; Bodek G; Jana B; Hansel W; Ziecik AJ
Exp Clin Endocrinol Diabetes; 2003 May; 111(3):146-53. PubMed ID: 12784188
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.
Vuorenoja S; Rivero-Müller A; Ziecik AJ; Huhtaniemi I; Toppari J; Rahman NA
Endocr Relat Cancer; 2008 Jun; 15(2):635-48. PubMed ID: 18509010
[TBL] [Abstract][Full Text] [Related]
4. Membrane disrupting lytic peptide conjugates destroy hormone dependent and independent breast cancer cells in vitro and in vivo.
Leuschner C; Enright FM; Gawronska B; Hansel W
Breast Cancer Res Treat; 2003 Mar; 78(1):17-27. PubMed ID: 12611453
[TBL] [Abstract][Full Text] [Related]
5. Effects of a lytic peptide conjugated to beta HCG on ovarian cancer: studies in vitro and in vivo.
Gawronska B; Leuschner C; Enright FM; Hansel W
Gynecol Oncol; 2002 Apr; 85(1):45-52. PubMed ID: 11925119
[TBL] [Abstract][Full Text] [Related]
6. Targeting breast and prostate cancers through their hormone receptors.
Leuschner C; Hansel W
Biol Reprod; 2005 Nov; 73(5):860-5. PubMed ID: 16033998
[TBL] [Abstract][Full Text] [Related]
7. Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors.
Leuschner C; Enright FM; Gawronska-Kozak B; Hansel W
Prostate; 2003 Sep; 56(4):239-49. PubMed ID: 12858351
[TBL] [Abstract][Full Text] [Related]
8. A novel approach of targeted ablation of mammary carcinoma cells through luteinizing hormone receptors using Hecate-CGbeta conjugate.
Bodek G; Rahman NA; Zaleska M; Soliymani R; Lankinen H; Hansel W; Huhtaniemi I; Ziecik AJ
Breast Cancer Res Treat; 2003 May; 79(1):1-10. PubMed ID: 12779076
[TBL] [Abstract][Full Text] [Related]
9. GA-Hecate antiviral properties on HCV whole cycle represent a new antiviral class and open the door for the development of broad spectrum antivirals.
Batista MN; Sanches PRDS; Carneiro BM; Braga ACS; Campos GRF; Cilli EM; Rahal P
Sci Rep; 2018 Sep; 8(1):14329. PubMed ID: 30254334
[TBL] [Abstract][Full Text] [Related]
10. Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors.
Rivero-Müller A; Vuorenoja S; Tuominen M; Wacławik A; Brokken LJ; Ziecik AJ; Huhtaniemi I; Rahman NA
Mol Cell Endocrinol; 2007 Apr; 269(1-2):17-25. PubMed ID: 17363137
[TBL] [Abstract][Full Text] [Related]
11. Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis.
You BR; Moon HJ; Han YH; Park WH
Food Chem Toxicol; 2010 May; 48(5):1334-40. PubMed ID: 20197077
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Evaluation of New Synthetic Bioconjugates Based on GA-Hecate: A New Class of Antivirals Targeting Different Steps of Zika Virus Replication.
da Silva Sanches PR; Velazquez RS; Batista MN; Carneiro BM; Bittar C; De Lorenzo G; Rahal P; Patel AH; Cilli EM
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446546
[TBL] [Abstract][Full Text] [Related]
13. A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.
Bodek G; Vierre S; Rivero-Müller A; Huhtaniemi I; Ziecik AJ; Rahman NA
Neoplasia; 2005 May; 7(5):497-508. PubMed ID: 15967102
[TBL] [Abstract][Full Text] [Related]
14. Designed antimicrobial and antitumor peptides with high selectivity.
Hu J; Chen C; Zhang S; Zhao X; Xu H; Zhao X; Lu JR
Biomacromolecules; 2011 Nov; 12(11):3839-43. PubMed ID: 21955251
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-tumor activity evaluation of gallic acid-mangiferin hybrid molecule.
Hu XY; Deng JG; Wang L; Yuan YF
Med Chem; 2013 Dec; 9(8):1058-62. PubMed ID: 23627273
[TBL] [Abstract][Full Text] [Related]
16. An amphipathic alpha-helical synthetic peptide analogue of melittin inhibits herpes simplex virus-1 (HSV-1)-induced cell fusion and virus spread.
Baghian A; Jaynes J; Enright F; Kousoulas KG
Peptides; 1997; 18(2):177-83. PubMed ID: 9149288
[TBL] [Abstract][Full Text] [Related]
17. Targeted destruction of androgen-sensitive and -insensitive prostate cancer cells and xenografts through luteinizing hormone receptors.
Leuschner C; Enright FM; Melrose PA; Hansel W
Prostate; 2001 Feb; 46(2):116-25. PubMed ID: 11170139
[TBL] [Abstract][Full Text] [Related]
18. Structure activity relationships of peptidic analogs of MyoD for the development of Id1 inhibitors as antiproliferative agents.
Hsiao YC; Yang DL; Hung HL; Lung FD
J Pept Sci; 2013 Nov; 19(11):676-83. PubMed ID: 24123584
[TBL] [Abstract][Full Text] [Related]
19. Free radical scavenging, cytotoxic, and hemolytic activities of an active antioxidant compound ethyl gallate from leaves of Acacia nilotica (L.) Wild. Ex. Delile subsp. indica (Benth.) Brenan.
Kalaivani T; Rajasekaran C; Mathew L
J Food Sci; 2011 Aug; 76(6):T144-9. PubMed ID: 22417526
[TBL] [Abstract][Full Text] [Related]
20. Destruction of breast cancers and their metastases by lytic peptide conjugates in vitro and in vivo.
Hansel W; Enright F; Leuschner C
Mol Cell Endocrinol; 2007 Jan; 260-262():183-9. PubMed ID: 17101210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
